Conflict of Interest Key Personnel

The University is required to maintain a website to ensure public accessibility to the Conflict of Interest (COI) in Research policy. Furthermore, the University is required to maintain information concerning any significant financial interest disclosed to the University that meets the following three criteria:

  • The significant financial interest was disclosed and is still held by the senior/key personnel;
  • The University determines that the significant financial interest is related to funded research or to scholarly and/or educational activities funded under external grants, contracts or cooperative agreements; and
  • The University determines that the significant financial interest is a Financial Conflict of Interest (FCOI).

The following personnel have met the above criteria. The information provided is current as of 08/18/2021 and is subject to updates, on at least an annual basis and within 60 days of the Institution’s identification of a new FCOI.

Personnel with Significant Financial Interests

Open All Tabs
  • Ahn, Yeon, M.D.

    Title/role: Team Member
    Name of SFI entity: RxMP Therapeutics, LLC
    Nature of SFI: Equity Ownership; Inventor of Intellectual Property
    Approximate Dollar Amount: Dr. Ahn owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • Alencar, Alvaro, M.D.

    Title/role: Team Member
    Name of SFI entity: Genetech
    Nature of SFI: consultant and scientific advisory board member
    Approximate Dollar Amount: Dr. Alencar received compensation from this company in the amount of $20,000-$100,000.

  • Alvarez, Ofelia, M.D.

    Title/role: Team Member
    Name of SFI entity: Novartis
    Nature of SFI: Consultant
    Approximate Dollar Amount: Dr. Alvarez has received compensation from this company in the amount of $5,000-$9,999.

  • Antoni, Michael Ph.D.

    Title/role: Principal Investigator
    Name of SFI entity: Blue Note Therapeutics 
    Nature of SFI: Consultant and Advisory Board Member
    Approximate Dollar Amount: Dr. Antoni has received compensation from this company in the amount of $10,000 - $24,999. 

  • Ayad, Nagy Ph.D.

    Title/role: Principal Investigator
    Name of SFI entity: Epigenetix
    Nature of SFI: Consultant and Equity holder
    Approximate Dollar Amount: Dr. Ayad owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.. 

  • Banerjee, Sulagna, Ph.D.

    Title/role: Principal Investigator and Team Member
    Name of SFI entity: Minneamrita Therapeutics
    Nature of SFI: Consultant
    Approximate Dollar Amount: Dr. Banerjee has received compensation from this company in the amount of $10,000-$20,000.

  • Barber, Glen, Ph.D.

    Title/role: Principal Investigator
    Name of SFI entity: StingInn
    Nature of SFI: Equity
    Approximate Dollar Amount: Dr. Barber owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value

  • Benedetto, Pasquale, M.D.

    Title/role: Team Member
    Name of SFI entity: Novartis
    Nature of SFI: Consultant and Advisory Board Member
    Approximate Dollar Amount: Dr. Benedetto has received compensation from this company in the amount of $5,000-$9,999.

  • Capobianco, Anthony, Ph.D.

    Title/role: Principal Investigator; Study Team Member
    Name of SFI entity: StemSynergy Therapeutics, Inc.
    Nature of SFI: Equity Ownership; Inventor of Intellectual Property
    Approximate Dollar Amount: Dr. Capobianco owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • Dakof, Gayle, Ph.D.

    Title/role: Co-Investigator
    Name of SFI entity: MDFT International
    Nature of SFI: Director
    Approximate Dollar Amount: Dr. Dakof received compensation as salary and travel from this company in the amount of $20,000-100,000. Dr. Dakof's spouse, Dr. Liddle, also has a professional relationship with this company. He received between $5,000-9,999 as the Chairman, Board of Directors, and consultant for MDT International.

  • Davis, Janet, M.D.

    Title/role: Principal Investigator
    Name of SFI entity: Allergan
    Nature of SFI: Consulting; Advisory Board
    Approximate Dollar Amount: Dr. Davis received compensation from this company in the amount of $5,000-9,999.

  • de Rivero Vaccari, Juan Pablo, Ph.D.

    Title/role: Team Member
    Name of SFI entity: InflamaCORE, LLC
    Nature of SFI: Equity Ownership; Inventor of Intellectual Property
    Approximate Dollar Amount: Dr. de Rivero Vaccari owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • Dhar, Shanta, Ph.D.

    Title/role: Principal Investigator
    Name of SFI entity: Partikula LLC
    Nature of SFI: Consultant; Equity Ownership; Inventor of Intellectual Property
    Approximate Dollar Amount: Dr. Dhar has received compensation in the amount of $20,000 - $100,000 from this company. In addition, Dr. Dhar owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • Dietrich, Dalton, Ph.D.

    Title/role: Principal Investigator
    Name of SFI entity: InflamaCORE, LLC
    Nature of SFI: Equity Ownership; Inventor of Intellectual Property
    Approximate Dollar Amount: Dr. Dietrich owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • Dobliecki-Lewis, Suzanne, M.D.

    Title/role: Team member
    Name of SFI entity: Gilead Pharmaceuticals
    Nature of SFI: Consultant
    Approximate Dollar Amount: Dr. Dobliecki-Lewis has received compensation in the amount of $0 - $10,000 from this company.

  • Dominguez-Bendala, Juan, Ph.D.

    Title/role: Principal Investigator
    Name of SFI entity: Ophysio, Inc
    Nature of SFI: Equity Ownership; Inventor of Intellectual Property
    Approximate Dollar Amount: Dr. Dominguez-Bendala owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • Doss, Brian Ph.D

    Title/role: Principal Investigator
    Name of SFI entity: Our Relationship, LLC
    Nature of SFI: Equity
    Approximate Dollar Amount: Dr. Doss owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.  
     

  • Ehrenreich-May, Jill, Ph.D.

    Title/role: Principal Investigator
    Name of SFI entity: Kinark Child and Family Services
    Nature of SFI: Teaching, training, Lecturing or speaking; Sponsored or reimbursed travel
    Approximate Dollar Amount: Dr. Ehrenreich-May received compensation from this company in the amount of $10,000-$19,999.

  • Fraker, Christopher, Ph.D.

    Title/role: Principle Investigator and Team Member
    Name of SFI entity: Ophysio, Inc
    Nature of SFI: Principal Investigator and Equity Ownership; Inventor of Intellectual Property
    Approximate Dollar Amount: Dr. Fraker owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • Franzmann, Elizabeth, M.D.

    Title/role: Team Member
    Name of SFI entity: Vigilant Biosciences
    Nature of SFI: Equity Ownership; Inventor of Intellectual Property
    Approximate Dollar Amount: Dr. Franzmann owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • Galvin, James MD, MPH

    Title/role: Principal Investigator
    Name of SFI entity: Washington University School of Medicine; New York University Langone Medical Center
    Nature of SFI: Royalties received as Inventor of Intellectual Property
    Approximate Dollar Amount: Dr. Galvin received royalties in the amount of $10,000-40,000.

  • Gilboa, Eli, Ph.D.

    Title/role: Principal Investigator
    Name of SFI entity: Sebastian Biopharma
    Nature of SFI: Equity Ownership
    Approximate Dollar Amount: Dr. Gilboa owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • Goldberger, Jeffrey, M.D.

    Title/role: Team Member
    Name of SFI entity: Gold-T Tech, Inc.
    Nature of SFI: Equity Ownership; Inventor of Intellectual Property
    Approximate Dollar Amount: Dr. Goldberger owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • Gustafson, David, Ph.D.

    Title/role: Sub-Contractor
    Name of SFI entity: D. Gustafson & Associates
    Nature of SFI: Sole Ownership; Consultant
    Approximate Dollar Amount: Dr. Gustafson received compensation as salary from this company in the amount of $20,000-100,000. He is also a consultant for this company.

  • Harbour, James, M.D.

    Title/role: Principal Investigator
    Name of SFI entity: Washington University; Castle Biosciences
    Nature of SFI: Royalties received as Inventor of Intellectual Property; Consultant
    Approximate Dollar Amount: Dr. Harbour received royalties in the amount of $20,000-40,000; compensation from this company in the amount of $10,000-20,000.

  • Hare, Joshua, M.D.

    Title/role: Principal Investigator
    Name of SFI entity: Vestion
    Nature of SFI: Equity Ownership
    Approximate Dollar Amount: Dr. Hare owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value. In addition, Dr. Hare has received compensation in the amount of $20,000 - $100,000.

     

    Title/role: Principal Investigator
    Name of SFI entity: Biscayne Pharmaceuticals
    Nature of SFI: Equity Ownership; Inventor of Intellectual Property
    Approximate Dollar Amount: Dr. Hare owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

     

    Title/role: Principal Investigator
    Name of SFI entity: Longeveron, LLC
    Nature of SFI: Equity Ownership; Chief Scientific Officer
    Approximate Dollar Amount: Dr. Hare owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value. In addition, Dr. Hare has received compensation in the amount of $250,000 - $299,999

  • Harvey, Philip, Ph.D.

    Title/role: Team Member
    Name of SFI entity: i-Function, Inc.
    Nature of SFI: Equity Ownership; Chief Scientific Officer
    Approximate Dollar Amount: Dr. Harvey owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • Hoffman, James, M.D.

    Title/role: Principal Investigator
    Name of SFI entity: Celgene
    Nature of SFI: consultant or scientific advisory board member and teaching, training, lecturing or speaking
    Approximate Dollar Amount: Dr. Hoffman received compensation from this company in the amount of $20,000-$100,000.

  • Jy, Wenche, Ph.D.

    Title/role: Team Member
    Name of SFI entity: RxMP Therapeutics, LLC
    Nature of SFI: Equity Ownership; Inventor of Intellectual Property
    Approximate Dollar Amount: Dr. Jy owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • Kasahara, Noriyuki, M.D., Ph.D.

    Title/role: Principal Investigator
    Name of SFI entity: Tocagen, Inc.
    Nature of SFI: Equity Ownership
    Approximate Dollar Amount: Dr. Kasahara owns equity in this company, in the amount of $700,000-$749,999.

  • Keane, Robert, Ph.D.

    Title/role: Team Member
    Name of SFI entity: InflamaCORE, LLC
    Nature of SFI: Equity Ownership; Inventor of Intellectual Property
    Approximate Dollar Amount: Dr. Keane owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • King, Roderick, Ph.D.

    Title/role: Principal Investigator
    Name of SFI entity: Florida Institute for Health Innovation (FIHI)
    Nature of SFI: Chief Executive Officer
    Approximate Dollar Amount: Dr. King has received less than $9,999 in compensation from FIHI.

  • Levy, Robert Ph.D.

    Title/role: Principal Investigator
    Name of SFI entity: Heat BiologicsHeat Biologics
    Nature of SFI: Equity ownership; consultant/advisory board member
    Approximate Dollar Amount: Dr. Levy owns equity in this publicly traded company in the range of $10,000 -19,999, and has received compensation from this company in the amount of $5,000-9,999.

     

    Title/role: Principal Investigator
    Name of SFI entity: Allergan
    Nature of SFI: Consultant
    Approximate Dollar Amount: Dr. Levy received compensation from this company in the amount of $5,000-9,999.

  • Larsson, Hans Ph.D.

    Title/role: Principal Investigator
    Name of SFI entity: VentricPharm
    Nature of SFI: Equity ownership
    Approximate Dollar Amount: Dr. Larsson owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • Liddle, Howard, E.D.D.

    Title/role: Principal Investigator; Study Team Member
    Name of SFI entity: MDFT International
    Nature of SFI: Chairman; Board of Directors; Consultant
    Approximate Dollar Amount: Dr. Liddle received compensation as salary from this company in the amount of $5,000-9,999. Dr. Liddle's spouse, Dr. Dakof, also has a professional relationship with this company. She received between $20,000-100,000 as the Director of MDFT International.

  • Mahtani, Reshma, D.O.

    Title/role: Team Member
    Name of SFI entity: Novartis
    Nature of SFI: Consultant and Advisory Board Member
    Approximate Dollar Amount: Dr. Mahtani has received compensation from this company in the amount of $10,000-24,999.

     

    Title/role: Team Member
    Name of SFI entity: AstraZeneca
    Nature of SFI: Consultant and Advisory Board Member
    Approximate Dollar Amount: Dr. Mahtani has received compensation from this company in the amount of $5,000-9,999.

     

    Title/role: Team Member
    Name of SFI entity: Pfizer
    Nature of SFI: Consultant and Advisory Board Member
    Approximate Dollar Amount: Dr. Mahtani has received compensation from this company in the amount of $10,000-24,999.

     

     

  • McCarthy, Micheline, M.D.

    Title/role: Team Member
    Name of SFI entity: Novartis
    Nature of SFI: Consultant and Advisory Board Member
    Approximate Dollar Amount: Dr. McCarthy has received compensation from this company in the amount of $5,000-$9,999.

  • Penedo, Frank Ph.D.

    Title/role: Principal Investigator
    Name of SFI entity: Blue Note Therapeutics
    Nature of SFI: Consultant and Advisory Board Member
    Approximate Dollar Amount: Dr. Penedo has received compensation from this company in the amount of $10,000 - $24,999.

  • Rajguru, Suhrud

    Title/role: PI
    Name of SFI entity: Restor-Ear, LLC
    Nature of SFI: Equity
    Approximate Dollar Amount: Dr. Rajguru owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
     

  • Rammohan, Kottil, M.D.

    Title/role: Team Member
    Name of SFI entity: Novartis
    Nature of SFI: Consultant and Advisory Board Member
    Approximate Dollar Amount: Dr. Rammohan has received compensation from this company in the amount of $5,000-$9,999.

     

    Title/role: Team Member
    Name of SFI entity: Genzyme
    Nature of SFI: Consultant and Advisory Board Member
    Approximate Dollar Amount: Dr. Rammohan has received compensation from this company in the amount of $5,000-$9,999.

  • Ricordi, Camillo, M.D.

    Title/role: Team Member
    Name of SFI entity: Ophysio, Inc
    Nature of SFI: Equity Ownership; Inventor of Intellectual Property; Advisory Board
    Approximate Dollar Amount: Dr. Ricordi owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • Robbins, David, Ph.D.

    Title/role: Principal Investigator/Team Member
    Name of SFI entity: StemSynergy Therapeutics
    Nature of SFI: Equity Ownership
    Approximate Dollar Amount: Dr. Robbins owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • Saluja, Ashok, Ph.D.

    Title/role: Principal Investigator
    Name of SFI entity: Minneamrita Therapeutics
    Nature of SFI: Equity; Inventor of Intellectual Property
    Approximate Dollar Amount: Dr. Saluja owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • Schüle, Rebecca, M.D.

    Title/role: Principal Investigator
    Name of SFI entity: ViaGenetics, LLC
    Nature of SFI: Consultant
    Approximate Dollar Amount: Dr. Schüle has received compensation in the amount of $0 - $10,000 from this company.

  • Shousha, Mohammad Abou, M.D.

    Title/role: Principal Investigator
    Name of SFI entity: Resolve Ophthalmics, LLC
    Nature of SFI: Equity Ownership
    Approximate Dollar Amount: Dr. Abou Shousha owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • Slomovitz, Brain, M.D.

    Title/role: Team member
    Name of SFI entity: Gilead Pharmaceuticals
    Nature of SFI: Consultant
    Approximate Dollar Amount: Dr. Dobliecki-Lewis has received compensation in the amount of $0 - $10,000 from this company.

  • Stock, Aaron

    Title/role: Team Member
    Name of SFI entity: Sernova
    Nature of SFI: Intellectual Property
    Approximate Dollar Amount: Mr. Stock has received $5,000 - $10,000 from the company.

     

     

  • Tomei, Alice Ph.D.

    Title/role: Principal Investigator
    Name of SFI entity: Sernova
    Nature of SFI: Intellectual Property
    Approximate Dollar Amount: Dr. Tomei has received $5,000 - $10,000 from the company

  • Webster, Keith, Ph.D.

    Title/role: Principal Investigator
    Name of SFI entity: Integene International
    Nature of SFI: Equity Ownership; Inventor of Intellectual Property; Board of Directors
    Approximate Dollar Amount: Dr. Webster owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • Yoo, Sonia, M.D.

    Title/role: Team Member
    Name of SFI entity: Resolve Ophthalmics, LLC
    Nature of SFI: Equity Ownership
    Approximate Dollar Amount: Dr. Yoo owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  • Züchner, Stephan, M.D.

    Title/role: Principal Investigator
    Name of SFI entity: ViaGenetics, LLC
    Nature of SFI: Equity Ownership; Board of Directors
    Approximate Dollar Amount: Dr. Dr. Züchner owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.